SUNPHARMA Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > sunpharma

Technical Analysis

Technical Strength: 3 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 34.2. According to RSI analysis, sunpharma is weak. 3.0 SUNPHARMA RSI Chart
MACD (?) MACD: -10.9 and Signal Line: -6.34. According to MACD analysis, sunpharma is technically weak. 2.0 SUNPHARMA MACD Chart
Simple Moving Average (?) According to simple moving average analysis, sunpharma is in a strong downtrend. Major resistance levels are 672.0425, 678.08, 711.631. 0.0 SUNPHARMA Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, sunpharma is in a strong downtrend. Major resistance levels are 666.5692, 672.754, 705.3041. 0.0 SUNPHARMA Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.116. According to bollinger bands, sunpharma is technically weak. 3.0 SUNPHARMA Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 662.5841, 675.275 and 687.9659. Support is at 621.5. 7.0 SUNPHARMA Fibonacci Retracement Chart
Average True Range (?) ATR: 14.6 NA SUNPHARMA Average True Range Chart
Average Directional Index (?) ADX is 19.1 which means SUNPHARMA is in a trading range and there is no trend. NA SUNPHARMA Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
April 26, 2017
Open Price 643.0
High Price 646.5
Low Price 635.1
Close Price 642.8
Absolute Change 0.25
Percentage Change 0.0389%
Weekly Change -3.1%
Monthly Change -7%
Yearly Change -22.8%
52-week high 854.95
52-week low 571.9
Corporate Actions
ExDate Purpose
September 08, 2016 AGM/DIV-RE 1/- PER SHARE
July 14, 2016 BUY BACK
October 21, 2015 AGM/DIV-RS 3 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.598
Confidence in Beta1.84%
Market Capital Rs. 154703.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 8.9
TTM Price-to-Earnings (P/E) Ratio 72.2
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 26 April 2017: Deliverable Quantity:1.02e+06 NA SUNPHARMA Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 26 April 2017: Daily Volatility:0.2694 NA SUNPHARMA Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 26 April 2017: PCR_OI:0.504 PCR:0.798 NA SUNPHARMA PCR Chart
Premium (?) 26 April 2017 Premium: 0.2 Futures OI:14969500.0 NA SUNPHARMA Premium Chart
Option_MAX_OI (?) 26 April 2017: Price:642.8 Put with maximum OI:660.0 Call with maximum OI:700.0 NA SUNPHARMA Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
April 27, 2017 643.0 14969500.0 11114.0 17671.0 642.8
May 25, 2017 645.25 18942700.0 6195.0 12232.0 642.8
June 29, 2017 649.4 128800.0 69.0 77.0 642.8

Announcements

April 25, 2017 SPress ReleaseSun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated April 25, 2017, titled "Press Release FDEC commences roll-out of Malaria demonstration project".
April 24, 2017 TNews ClarificationThe Exchange has sought clarification from the Company with respect to news item captioned "FDA issues 11 observations for Dadra unit". The response from the Company is enclosed.
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 27, 2017 February 14, 2017 TResultsTo consider and take on record the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2016.
October 25, 2016 November 10, 2016 TResults/OthersTo transact, interalia, the following business:
See all Board Meetings

SUNPHARMA is part of...

Index Weightage
NIFTY NA
CNXPHARMA NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 625 Rs. 630.1 Rs. 636.4 Rs. 641.5 Rs. 647.8 Rs. 652.9 Rs. 659.2